Outcomes of Hematopoietic Stem Cell Transplant in Transfusion Dependent Thalassemia: A Single Center Experience from Low Middle Income Country

Key Points

• Transplant outcomes show a significant improvement in hemoglobin levels in patients with thalassemia.
• Around 80% of patients achieved transfusion independence within two years after the transplant.
• Observational analysis at a single center demonstrates the feasibility and effectiveness of stem cell transplants.
• Highlights the need for more accessible transplant options in low-middle income countries.